Annual Cash & Cash Equivalents
$80.45 M
-$69.32 M-46.29%
31 December 2023
Summary:
Humacyte annual cash & cash equivalents is currently $80.45 million, with the most recent change of -$69.32 million (-46.29%) on 31 December 2023. During the last 3 years, it has risen by +$40.52 million (+101.48%). HUMA annual cash & cash equivalents is now -63.01% below its all-time high of $217.50 million, reached on 31 December 2021.HUMA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$20.57 M
-$72.99 M-78.01%
30 September 2024
Summary:
Humacyte quarterly cash and cash equivalents is currently $20.57 million, with the most recent change of -$72.99 million (-78.01%) on 30 September 2024. Over the past year, it has dropped by -$79.42 million (-79.43%). HUMA quarterly cash and cash equivalents is now -91.44% below its all-time high of $240.45 million, reached on 30 September 2021.HUMA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUMA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.3% | -79.4% |
| 3 y3 years | +101.5% | -91.4% |
| 5 y5 years | - | - |
HUMA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.0% | +101.5% | -91.4% | at low |
| 5 y | 5 years | -63.0% | +101.5% | -91.4% | at low |
| alltime | all time | -63.0% | +101.5% | -91.4% | at low |
Humacyte Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.57 M(-78.0%) |
| June 2024 | - | $93.56 M(-19.0%) |
| Mar 2024 | - | $115.50 M(+43.6%) |
| Dec 2023 | $80.45 M(-46.3%) | $80.45 M(-19.5%) |
| Sept 2023 | - | $99.99 M(-12.8%) |
| June 2023 | - | $114.60 M(-11.6%) |
| Mar 2023 | - | $129.57 M(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $149.77 M(-31.1%) | $149.77 M(-8.5%) |
| Sept 2022 | - | $163.73 M(-9.6%) |
| June 2022 | - | $181.03 M(-8.7%) |
| Mar 2022 | - | $198.22 M(-8.9%) |
| Dec 2021 | $217.50 M(+444.7%) | $217.50 M(-9.5%) |
| Sept 2021 | - | $240.45 M(+502.2%) |
| Dec 2020 | $39.93 M | $39.93 M |
FAQ
- What is Humacyte annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Humacyte?
- What is Humacyte annual cash & cash equivalents year-on-year change?
- What is Humacyte quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Humacyte?
- What is Humacyte quarterly cash and cash equivalents year-on-year change?
What is Humacyte annual cash & cash equivalents?
The current annual cash & cash equivalents of HUMA is $80.45 M
What is the all time high annual cash & cash equivalents for Humacyte?
Humacyte all-time high annual cash & cash equivalents is $217.50 M
What is Humacyte annual cash & cash equivalents year-on-year change?
Over the past year, HUMA annual cash & cash equivalents has changed by -$69.32 M (-46.29%)
What is Humacyte quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HUMA is $20.57 M
What is the all time high quarterly cash and cash equivalents for Humacyte?
Humacyte all-time high quarterly cash and cash equivalents is $240.45 M
What is Humacyte quarterly cash and cash equivalents year-on-year change?
Over the past year, HUMA quarterly cash and cash equivalents has changed by -$79.42 M (-79.43%)